ABRT Stock Overview
A biopharmaceutical drug discovery company, researches and develops drugs for psychedelic-assisted therapy for patients with urgent and unmet needs in Canada and the United Kingdom. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Albert Labs International Corp. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.005 |
| 52 Week High | CA$0.035 |
| 52 Week Low | CA$0.005 |
| Beta | 3.13 |
| 11 Month Change | 0% |
| 3 Month Change | 0% |
| 1 Year Change | -50.00% |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -98.00% |
Recent News & Updates
Recent updates
Shareholder Returns
| ABRT | CA Biotechs | CA Market | |
|---|---|---|---|
| 7D | 0% | -2.9% | 2.1% |
| 1Y | -50.0% | -8.6% | 23.4% |
Return vs Industry: ABRT underperformed the Canadian Biotechs industry which returned -20.6% over the past year.
Return vs Market: ABRT underperformed the Canadian Market which returned 23.4% over the past year.
Price Volatility
| ABRT volatility | |
|---|---|
| ABRT Average Weekly Movement | n/a |
| Biotechs Industry Average Movement | 11.8% |
| Market Average Movement | 8.3% |
| 10% most volatile stocks in CA Market | 17.7% |
| 10% least volatile stocks in CA Market | 2.9% |
Stable Share Price: ABRT's share price has been volatile over the past 3 months compared to the Canadian market.
Volatility Over Time: Insufficient data to determine ABRT's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | n/a | Chand Jagpal | albertlabs.com |
Albert Labs International Corp., a biopharmaceutical drug discovery company, researches and develops drugs for psychedelic-assisted therapy for patients with urgent and unmet needs in Canada and the United Kingdom. It develops KRN-101, is a solution for cancer-related anxiety. The company is based in Burnaby, Canada.
Albert Labs International Corp. Fundamentals Summary
| ABRT fundamental statistics | |
|---|---|
| Market cap | CA$372.07k |
| Earnings (TTM) | -CA$2.31m |
| Revenue (TTM) | n/a |
0.0x
P/S Ratio-0.2x
P/E RatioIs ABRT overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ABRT income statement (TTM) | |
|---|---|
| Revenue | CA$0 |
| Cost of Revenue | CA$0 |
| Gross Profit | CA$0 |
| Other Expenses | CA$2.31m |
| Earnings | -CA$2.31m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.031 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | -2.3% |
How did ABRT perform over the long term?
See historical performance and comparison